Author Topic: Could the gut microbiome be a new therapeutic target for MS?  (Read 40 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8520
  • MS diagnosed 1980
  • Location: Pacific Northwest
This article concerns a paper published in the Journal of Interferon and Cytokine Research, which is on the AAAS list of peer-reviewed scientific journals. From Medical News Today, July 8, 2016:

Could the gut microbiome be a new therapeutic target for multiple sclerosis?

An increasing number of clinical studies are pointing to a link between the autoimmune disease multiple sclerosis (MS) and the composition of microbes in the human gut, sparking new research on the gut microbiome as a potential target for MS treatment and prevention. A comprehensive review article examining the proposed role of gut bacteria and the viruses that infect them in the development and progression of MS is published in Journal of Interferon & Cytokine Research (JICR) from Mary Ann Liebert, Inc., publishers. The article is available free on the JICR website until August 6, 2016.

In the article "Emerging Concepts on the Gut Microbiome and Multiple Sclerosis," coauthors Justin Glenn and Ellen Mowry, Johns Hopkins University School of Medicine (Baltimore, MD) discuss the mechanisms by which altered levels of bacteria in the human gut-or the activity of bacteriophage, viruses that attack bacteria, or of bacterial toxins-can affect the immune system and possibly have a role in autoimmune disorders such as MS, in which the body attacks itself. Understanding these mechanisms could lead to the identification of novel drug targets and preventive strategies.

"This informative review presents the facts behind the notion that the nature of the intestinal microbial population may influence the development of autoimmune diseases, such as MS," says Journal of Interferon & Cytokine Research Co-Editor-in-Chief Ganes C. Sen, PhD, Department of Immunology, Cleveland Clinic Foundation.


Article: Emerging Concepts on the Gut Microbiome and Multiple Sclerosis, Glenn Justin D. and Mowry Ellen M., Journal of Interferon & Cytokine Research, doi:10.1089/jir.2015.0177, published online 4 May 2016.

The above article can be seen here.
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.


Related Topics

  Subject / Started by Replies Last post
0 Replies
Last post October 10, 2017, 09:57:07 am
by agate